ARCHIVES

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Bass & Howes Bought By DDB Seattle

March 22, 2002